BioNano Genomics stock price down 2.14% on Friday
(Updated on Sep 30, 2022)
Sell candidate since 2022-09-20 Loss -14.08% PDF
The BioNano Genomics stock price fell by -2.14% on the last day (Friday, 30th Sep 2022) from $1.87 to $1.83. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.56% from a day low at $1.83 to a day high of $1.95. The price has fallen in 8 of the last 10 days and is down by -17.94% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -921 thousand shares and in total, 3 million shares were bought and sold for approximately $5.40 million.
Given the current short-term trend, the stock is expected to rise 18.54% during the next 3 months and, with a 90% probability hold a price between $2.17 and $4.65 at the end of this 3-month period.
Signals & Forecast
There are few to no technical positive signals at the moment. The BioNano Genomics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.86 and $2.44. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, August 15, 2022, and so far it has fallen -49.17%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.12 between high and low, or 6.56%. For the last week, the stock has had daily average volatility of 7.13%.
BioNano Genomics is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect BioNano Genomics Inc. to open at $1.87, and during the day (based on 14 day Average True Range), to move between $1.66 and $2.00, which gives a possible trading interval of +/-$0.17 (+/-9.49%) up or down from last closing price. If BioNano Genomics Inc. takes out the full calculated possible swing range there will be an estimated 18.98% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.86 (1.64%) than the support at $1.78 (2.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is BioNano Genomics Inc. stock A Buy?
The BioNano Genomics stock holds several negative signals and despite the positive trend, we believe BioNano Genomics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -3.503Sell Candidate Unchanged
Predicted Opening Price for BioNano Genomics Inc. of Monday, October 3, 2022
The predicted opening price is based on yesterday's movements between high, low, and closing price.
|Fair opening price October 3, 2022||Current price|
Remember To Visit Our YouTube Channel
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
About BioNano Genomics Inc.
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents ... BNGO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.